logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kenneth B. Gordon

university of toronto

73H-index
309Paper Count
2.6WCitation Count
Published Papers 134
Publication Date
logo
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2025-10-01
err1
errOAAI
errGold, Linda Stein; Gottlieb, Alice B.; Armstrong, April W.; Alkousakis, Theodore; Bissonnette, Robert; Langley, Richard G.; Krueger, James; Papp, Kim; Choi, Olivia; Rowland, Katelyn; Chan, Daphne; Jeyarajah, Jenny; Park-Wyllie, Laura; Gao, Long-Long; Gordon, Kenneth B.; Merola, Joseph F.; Lebwohl, Mark G.; Strober, Bruce
errShare
errSave
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies
errAmerican Journal of Clinical Dermatology
IF8.8
err2025-08-31
err0
errOAAI
errJoseph F. Merola; Richard B. Warren; Diamant Thaçi; Kenneth B. Gordon; Emi Nishida; Bruce Strober; Curdin Conrad; Sarah Kavanagh; José Manuel López Pinto; Bengt Hoepken; Paolo Gisondi
errShare
errSave
Biologic Sequence for the Treatment of Psoriatic Arthritis Following Nonresponse: A Narrative Review
errDermatology and Therapy
IF4.2
err2025-07-18
err0
errOAAI
errNicole D. Boswell; Alexa Ries; Kenneth B. Gordon; Shikha Singla
errShare
errSave
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease
errinfectious disease clinics of north america
IF2.9
err2025-06-03
err0
PREAI
errEric M. Ruderman; Kenneth B. Gordon
errShare
errSave
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial
errJournal of the American Academy of Dermatology
IF11.8
err2025-04-24
err0
errOAAI
errAndrew Blauvelt; Richard G. Langley; Mark Lebwohl; Bruce Strober; Richard B. Warren; Luis Puig; Akimichi Morita; Kenneth B. Gordon; Pablo Fernandez-Peñas; Sarah Kavanagh; José M. López Pinto; Jérémy Lambert; Bengt Hoepken; Delphine Deherder; Nancy Cross; Diamant Thaçi
errShare
errSave
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions (vol 15, pg 395, 2025)
errDERMATOLOGY AND THERAPY
IF4.2
err2025-04-01
err0
errOAAI
errGordon, Kenneth B.; Tada, Yayoi; Anadkat, Milan J.; Choon, Siew Eng; Elewski, Boni; Barker, Jonathan N.; Mostaghimi, Arash; Eyerich, Kilian; Tang, Ming; Haeufel, Thomas; Thoma, Christian; Thaci, Diamant
errShare
errSave
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials (vol 14, pg 2235, 2024)
errDERMATOLOGY AND THERAPY
IF4.2
err2025-03-01
err0
errOAAI
errArmstrong, April W.; Augustin, Matthias; Beaumont, Jennifer L.; Pham, Tan P.; Hudgens, Stacie; Gordon, Kenneth B.; Zhuo, Joe; Becker, Brandon; Zhong, Yichen; Kisa, Renata M.; Banerjee, Subhashis; Papp, Kim A.
errShare
errSave
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions
errDERMATOLOGY AND THERAPY
IF4.2
err2025-02-10
err1
errOAAI
errGordon, Kenneth B.; Tada, Yayoi; Anadkat, Milan J.; Choon, Siew Eng; Elewski, Boni; Barker, Jonathan N.; Mostaghimi, Arash; Eyerich, Kilian; Tang, Ming; Haeufel, Thomas; Thoma, Christian; Thaci, Diamant
errShare
errSave
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis
errDERMATOLOGY AND THERAPY
IF4.2
err2024-08-23
err4
errOAAI
errArmstrong, April W.; Foley, Peter; Liu, Yan; Miller, Megan; Teneralli, Rachel E.; Bewley, Anthony; Gordon, Kenneth B.; Papp, Kim A.; Han, Chenglong
errShare
errSave
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials
errDERMATOLOGY AND THERAPY
IF4.2
err2024-08-17
err3
errOAAI
errGordon, Kenneth B.; Blauvelt, Andrew; Bachelez, Herve; Coates, Laura C.; Van den Bosch, Filip E.; Kaplan, Blair; Koetse, Willem; Ashley, Doug G.; Lippe, Ralph; Sinvhal, Ranjeeta; Papp, Kim A.
errShare
errSave
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials
errDERMATOLOGY AND THERAPY
IF4.2
err2024-07-30
err3
errOAAI
errArmstrong, April W.; Augustin, Matthias; Beaumont, Jennifer L.; Pham, Tan P.; Hudgens, Stacie; Gordon, Kenneth B.; Zhuo, Joe; Becker, Brandon; Zhong, Yichen; Kisa, Renata M.; Banerjee, Subhashis; Papp, Kim A.
errShare
errSave
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?
errAMERICAN JOURNAL OF CLINICAL DERMATOLOGY
IF8.8
err2024-07-13
err1
PREAI
errBoswell, Nicole D.; Singla, Shikha; Gordon, Kenneth B.
errShare
errSave
Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2)
errJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
err2024-03-07
err5
errOAAI
errStrober, Bruce; Blauvelt, Andrew; Warren, Richard B.; Papp, Kim A.; Armstrong, April W.; Gordon, Kenneth B.; Morita, Akimichi; Alexis, Andrew F.; Lebwohl, Mark; Foley, Peter; Kisa, Renata M.; Colston, Elizabeth; Wang, Tao; Banerjee, Subhashis; Thaci, Diamant
errShare
errSave
Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary
errJAMA DERMATOLOGY
IF11
err2024-02-01
err3
errOAAI
errPapp, Kim A.; Gordon, Kenneth; Strober, Bruce; Zhuo, Joe; Becker, Brandon; Zhong, Yichen; Beaumont, Jennifer L.; Pham, Tan P.; Kisa, Renata; Napoli, Andrew A.; Banerjee, Subhashis; Armstrong, April W.
errShare
errSave
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials
errBRITISH JOURNAL OF DERMATOLOGY
IF9.6
err2023-11-10
err9
errOAAI
errGordon, Kenneth B.; Langley, Richard G.; Warren, Richard B.; Okubo, Yukari; Rosmarin, David; Lebwohl, Mark; Peterson, Luke; Madden, Cynthia; de Cuyper, Dirk; Davies, Owen; Thaci, Diamant
errShare
errSave
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review
errDERMATOLOGY AND THERAPY
IF4.2
err2023-11-04
err18
errOAAI
errBlauvelt, Andrew; Langley, Richard G.; Gordon, Kenneth B.; Silverberg, Jonathan I.; Eyerich, Kilian; Sommer, Morten O. A.; Felding, Jakob; Warren, Richard B.
errShare
errSave
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
errLANCET
IF88.5
err2023-10-01
err38
PREAI
errMorita, Akimichi; Strober, Bruce; Burden, A. David; Choon, Siew Eng; Anadkat, Milan J.; Marrakchi, Slaheddine; Tsai, Tsen-Fang; Gordon, Kenneth B.; Thaci, Diamant; Zheng, Min; Hu, Na; Haeufel, Thomas; Thoma, Christian; Lebwohl, Mark G.
errShare
errSave
The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
errADVANCES IN THERAPY
IF4
err2023-09-22
err6
errOAAI
errRamcharran, Darmendra; Strober, Bruce; Gordon, Kenneth; Deklotz, Cynthia; Fakharzadeh, Steven; Yang, Ya-Wen; Swerdel, Joel; Hardin, Jill; Dronavalli, Sridhar; Paller, Amy S.
errShare
errSave
Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis Reply
errLANCET RHEUMATOLOGY
IF16.4
err2023-06-01
err0
PREAI
errSingla, Shikha; Putman, Michael; Liew, Jean; Gordon, Kenneth
errShare
errSave
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study
errLANCET RHEUMATOLOGY
IF16.4
err2023-04-01
err39
PREAI
errSingla, Shikha; Putman, Michael; Liew, Jean; Gordon, Kenneth
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
D
Dafna D. Gladman
H-index: 143 · Papers: 1.6K
J
James G. Krueger
H-index: 143 · Papers: 748
C
C.E.M. Griffiths
H-index: 131 · Papers: 1.3K
M
Mark Lebwohl
H-index: 120 · Papers: 1.4K
P
Philip J. Mease
H-index: 117 · Papers: 1.1K
View more